Elevated TROP-2 expression has been noted in thyroid cancers, though some studies report sensitivity as high as 100%, raising concerns about the reliability of these results due to small sample sizes [20, 29]. The gene discussed is TACSTD2; the disease is thyroid gland carcinoma.